Prediction of MGMT promotor methylation status in glioblastoma by contrast-enhanced T1-weighted intensity image.
Sanada T, Kinoshita M, Sasaki T, Yamamoto S, Fujikawa S, Fukuyama S, Hayashi N, Fukai J, Okita Y, Nonaka M, Uda T, Arita H, Mori K, Ishibashi K, Takano K, Nishida N, Shofuda T, Yoshioka E, Kanematsu D, Tanino M, Kodama Y, Mano M, Kanemura Y.
Sanada T, et al. Among authors: kinoshita m.
Neurooncol Adv. 2024 Feb 1;6(1):vdae016. doi: 10.1093/noajnl/vdae016. eCollection 2024 Jan-Dec.
Neurooncol Adv. 2024.
PMID: 38410136
Free PMC article.